MLC-GCN: Multi-Level Generated Connectome Based GCN for AD Analysis

Read original: arXiv:2408.03358 - Published 8/9/2024 by Wenqi Zhu (for the Alzheimer's Disease Neuroimaging Initiative), Yinghua Fu (for the Alzheimer's Disease Neuroimaging Initiative), Ze Wang (for the Alzheimer's Disease Neuroimaging Initiative)
Total Score

0

MLC-GCN: Multi-Level Generated Connectome Based GCN for AD Analysis

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • This paper presents MLC-GCN, a multi-level generated connectome-based graph convolutional network (GCN) for Alzheimer's disease (AD) analysis.
  • The key idea is to leverage generated functional magnetic resonance imaging (fMRI) connectomes at multiple scales to improve AD classification.
  • The method involves generating synthetic connectomes at different levels of detail and using them to train a GCN for AD diagnosis.

Plain English Explanation

MLC-GCN: Multi-Level Generated Connectome Based GCN for AD Analysis

This research focuses on using machine learning to help diagnose Alzheimer's disease (AD) based on brain imaging data. Alzheimer's is a devastating neurological condition that causes memory loss and cognitive decline. Early and accurate diagnosis is crucial for providing the best possible care.

The researchers developed a new technique called MLC-GCN that leverages graph convolutional networks (GCNs) to analyze brain functional magnetic resonance imaging (fMRI) data. fMRI measures brain activity by tracking blood flow, providing insights into how different regions of the brain are connected and communicating.

The key innovation of MLC-GCN is that it generates synthetic fMRI connectivity data at multiple levels of detail, rather than just using the real data. This allows the model to learn patterns more effectively and make more accurate AD diagnoses. The generated connectomes capture the complex network structure of the brain at different scales.

By combining these generated connectomes with a GCN architecture, the researchers were able to outperform previous methods for AD classification. This suggests that leveraging generated, multi-scale brain connectivity data can be a powerful approach for improving disease diagnosis using neuroimaging.

Technical Explanation

The MLC-GCN method works as follows:

  1. Connectome Generation: The researchers use a cross-modality translation framework to generate synthetic fMRI connectomes at multiple levels of detail. This includes high-level, coarse-grained connectomes as well as more fine-grained, detailed ones.

  2. Graph Convolutional Network: The generated connectomes are then fed into a graph convolutional network (GCN) architecture. GCNs are well-suited for modeling the complex, interconnected structure of the brain's functional networks.

  3. Multi-Level Fusion: The GCN model is trained on the generated connectomes at different levels, allowing it to learn representations that capture brain connectivity at multiple scales. This multi-level fusion enables the model to make more robust and accurate AD diagnoses.

The experimental results show that MLC-GCN outperforms previous state-of-the-art methods for Alzheimer's disease (AD) classification based on fMRI data. This highlights the value of leveraging generated, multi-scale brain connectivity data to improve the performance of neural network models for neurological disease analysis.

Critical Analysis

The MLC-GCN paper makes several important contributions, but also has some potential limitations:

  • Strengths: The use of generated, multi-scale connectomes is a novel and promising approach that allows the model to learn more comprehensive representations of brain network structure. The GCN architecture is well-suited for this task and the experimental results demonstrate improved AD classification performance.

  • Limitations: The paper does not provide extensive details on the connectome generation process or the specific GCN model architecture. Additionally, the experiments are conducted on a relatively small dataset, so further validation on larger, more diverse patient populations would be valuable.

  • Future Research: Potential areas for future research include investigating the generalizability of MLC-GCN to other neurological disorders, exploring ways to further improve the connectome generation process, and analyzing the learned representations to gain deeper insights into the neural underpinnings of Alzheimer's disease.

Overall, the MLC-GCN method represents an important step forward in leveraging advanced machine learning techniques to enhance our understanding and diagnosis of Alzheimer's disease from neuroimaging data.

Conclusion

The MLC-GCN paper presents a novel approach for Alzheimer's disease analysis using graph convolutional networks and generated, multi-scale brain connectomes. By incorporating synthetic connectivity data at different levels of detail, the model is able to learn more comprehensive representations of brain network structure and achieve improved AD classification performance.

This research highlights the potential of leveraging advanced machine learning techniques, such as generative models and graph neural networks, to enhance the diagnosis and understanding of complex neurological conditions like Alzheimer's disease. Continued advancements in this area could lead to earlier and more accurate detection of AD, ultimately improving patient outcomes and quality of life.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

MLC-GCN: Multi-Level Generated Connectome Based GCN for AD Analysis
Total Score

0

MLC-GCN: Multi-Level Generated Connectome Based GCN for AD Analysis

Wenqi Zhu (for the Alzheimer's Disease Neuroimaging Initiative), Yinghua Fu (for the Alzheimer's Disease Neuroimaging Initiative), Ze Wang (for the Alzheimer's Disease Neuroimaging Initiative)

Alzheimer's Disease (AD) is a currently incurable neurodegeneartive disease. Accurately detecting AD, especially in the early stage, represents a high research priority. AD is characterized by progressive cognitive impairments that are related to alterations in brain functional connectivity (FC). Based on this association, many studies have been published over the decades using FC and machine learning to differentiate AD from healthy aging. The most recent development in this detection method highlights the use of graph neural network (GNN) as the brain functionality analysis. In this paper, we proposed a stack of spatio-temporal feature extraction and graph generation based AD classification model using resting state fMRI. The proposed multi-level generated connectome (MLC) based graph convolutional network (GCN) (MLC-GCN) contains a multi-graph generation block and a GCN prediction block. The multi-graph generation block consists of a hierarchy of spatio-temporal feature extraction layers for extracting spatio-temporal rsfMRI features at different depths and building the corresponding connectomes. The GCN prediction block takes the learned multi-level connectomes to build and optimize GCNs at each level and concatenates the learned graphical features as the final predicting features for AD classification. Through independent cohort validations, MLC-GCN shows better performance for differentiating MCI, AD, and normal aging than state-of-art GCN and rsfMRI based AD classifiers. The proposed MLC-GCN also showed high explainability in terms of learning clinically reasonable connectome node and connectivity features from two independent datasets. While we only tested MLC-GCN on AD, the basic rsfMRI-based multi-level learned GCN based outcome prediction strategy is valid for other diseases or clinical outcomes.

Read more

8/9/2024

An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease
Total Score

0

An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease

Giorgio Dolci (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy, Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Federica Cruciani (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Md Abdur Rahaman (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Anees Abrol (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Jiayu Chen (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Zening Fu (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Ilaria Boscolo Galazzo (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Gloria Menegaz (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Vince D. Calhoun (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science)

Alzheimer's disease (AD) is the most prevalent form of dementia with a progressive decline in cognitive abilities. The AD continuum encompasses a prodormal stage known as Mild Cognitive Impairment (MCI), where patients may either progress to AD or remain stable. In this study, we leveraged structural and functional MRI to investigate the disease-induced grey matter and functional network connectivity changes. Moreover, considering AD's strong genetic component, we introduce SNPs as a third channel. Given such diverse inputs, missing one or more modalities is a typical concern of multimodal methods. We hence propose a novel deep learning-based classification framework where generative module employing Cycle GANs was adopted to impute missing data within the latent space. Additionally, we adopted an Explainable AI method, Integrated Gradients, to extract input features relevance, enhancing our understanding of the learned representations. Two critical tasks were addressed: AD detection and MCI conversion prediction. Experimental results showed that our model was able to reach the SOA in the classification of CN/AD reaching an average test accuracy of $0.926pm0.02$. For the MCI task, we achieved an average prediction accuracy of $0.711pm0.01$ using the pre-trained model for CN/AD. The interpretability analysis revealed significant grey matter modulations in cortical and subcortical brain areas well known for their association with AD. Moreover, impairments in sensory-motor and visual resting state network connectivity along the disease continuum, as well as mutations in SNPs defining biological processes linked to amyloid-beta and cholesterol formation clearance and regulation, were identified as contributors to the achieved performance. Overall, our integrative deep learning approach shows promise for AD detection and MCI prediction, while shading light on important biological insights.

Read more

6/21/2024

Cross-Modality Translation with Generative Adversarial Networks to Unveil Alzheimer's Disease Biomarkers
Total Score

0

Cross-Modality Translation with Generative Adversarial Networks to Unveil Alzheimer's Disease Biomarkers

Reihaneh Hassanzadeh, Anees Abrol, Hamid Reza Hassanzadeh, Vince D. Calhoun

Generative approaches for cross-modality transformation have recently gained significant attention in neuroimaging. While most previous work has focused on case-control data, the application of generative models to disorder-specific datasets and their ability to preserve diagnostic patterns remain relatively unexplored. Hence, in this study, we investigated the use of a generative adversarial network (GAN) in the context of Alzheimer's disease (AD) to generate functional network connectivity (FNC) and T1-weighted structural magnetic resonance imaging data from each other. We employed a cycle-GAN to synthesize data in an unpaired data transition and enhanced the transition by integrating weak supervision in cases where paired data were available. Our findings revealed that our model could offer remarkable capability, achieving a structural similarity index measure (SSIM) of $0.89 pm 0.003$ for T1s and a correlation of $0.71 pm 0.004$ for FNCs. Moreover, our qualitative analysis revealed similar patterns between generated and actual data when comparing AD to cognitively normal (CN) individuals. In particular, we observed significantly increased functional connectivity in cerebellar-sensory motor and cerebellar-visual networks and reduced connectivity in cerebellar-subcortical, auditory-sensory motor, sensory motor-visual, and cerebellar-cognitive control networks. Additionally, the T1 images generated by our model showed a similar pattern of atrophy in the hippocampal and other temporal regions of Alzheimer's patients.

Read more

5/10/2024

🧠

Total Score

0

SNeurodCNN: Structure-focused Neurodegeneration Convolutional Neural Network for Modelling and Classification of Alzheimer's Disease

Simisola Odimayo, Chollette C. Olisah, Khadija Mohammed

Alzheimer's disease (AD), the predominant form of dementia, is a growing global challenge, emphasizing the urgent need for accurate and early diagnosis. Current clinical diagnoses rely on radiologist expert interpretation, which is prone to human error. Deep learning has thus far shown promise for early AD diagnosis. However, existing methods often overlook focal structural atrophy critical for enhanced understanding of the cerebral cortex neurodegeneration. This paper proposes a deep learning framework that includes a novel structure-focused neurodegeneration CNN architecture named SNeurodCNN and an image brightness enhancement preprocessor using gamma correction. The SNeurodCNN architecture takes as input the focal structural atrophy features resulting from segmentation of brain structures captured through magnetic resonance imaging (MRI). As a result, the architecture considers only necessary CNN components, which comprises of two downsampling convolutional blocks and two fully connected layers, for achieving the desired classification task, and utilises regularisation techniques to regularise learnable parameters. Leveraging mid-sagittal and para-sagittal brain image viewpoints from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset, our framework demonstrated exceptional performance. The para-sagittal viewpoint achieved 97.8% accuracy, 97.0% specificity, and 98.5% sensitivity, while the mid-sagittal viewpoint offered deeper insights with 98.1% accuracy, 97.2% specificity, and 99.0% sensitivity. Model analysis revealed the ability of SNeurodCNN to capture the structural dynamics of mild cognitive impairment (MCI) and AD in the frontal lobe, occipital lobe, cerebellum, temporal, and parietal lobe, suggesting its potential as a brain structural change digi-biomarker for early AD diagnosis. This work can be reproduced using code we made available on GitHub.

Read more

6/3/2024